MIR302CHG

Across TCGA pan-cancer cohorts, MIR302CHG RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR302CHG data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR302CHG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR302CHG expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

BLCA, KICH, and SKCM are the cancer types where MIR302CHG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.431	0.249	.006	55	view →
KICH	DFS	Tertile	III,IV	0.247	1.000	.013	48	view →
SKCM	OS	Tertile	III,IV	0.769	0.523	.002	42	view →
LGG	DFS	Median	All	0.321	0.463	<.001	38	view →
THCA	OS	Median	II,III,IV	0.923	1.000	.006	35	view →
HNSC	OS	Tertile	All	0.823	0.686	.005	30	view →
CHOL	DFS	Quartile	All	0.640	0.121	.006	25	view →
ACC	OS	Tertile	All	0.421	0.777	.007	25	view →
UVM	DFS	Tertile	All	0.553	1.000	.010	17	view →
THYM	DFS	Quartile	II,III,IV	1.000	0.562	.014	13	view →
KIRC	DFS	Quartile	III,IV	0.295	0.615	.012	13	view →
MESO	DFS	Quartile	IV	0.073	0.487	.004	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR302CHG–BLCA (DFS)

Open the BLCA breakdown →